Skip to main content
FinSpry Logo
FinSpry
IMNM logo
IMNM
(NASDAQ)
Immunome, Inc.
$26.12-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Immunome, Inc. (IMNM) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Immunome, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(11 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$37.40
↑ 43.19% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest IMNM Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Unknown Analyst
Wedbush
BuyMaintains
$31.00 → $35.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Andres Y. Maldonado
HC Wainwright
BuyReiterates
$40.00
Lukas Shumway
Barclays
BuyMaintains
$36.00
Charles Zhu
LifeSci Capital
BuyMaintains
$40.00
Brian Cheng
JP Morgan
BuyMaintains
-
Brian Cheng
JP Morgan
BuyMaintains
-
Unknown Analyst
Wedbush
BuyMaintains
$31.00
Brian Cheng
JP Morgan
BuyReiterates
$39.00
Adam Vogel
Craig-Hallum
BuyReiterates
$36.00
Charles Zhu
LifeSci Capital
BuyMaintains
$20.00 → $40.00

Frequently Asked Questions

What is the analyst consensus rating for IMNM?

The analyst consensus rating for IMNM is "Buy" based on 7 analyst recommendations.

What is the average price target for IMNM?

The average 12-month price target for IMNM is $37.40, representing an upside of 43.2% from the current price of $26.12.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.